Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

miRNA-93-5p and other miRNAs as predictors of coronary artery disease and STEMI.

O Sullivan JF, Neylon A, McGorrian C, Blake GJ.

Int J Cardiol. 2016 Dec 1;224:310-316. doi: 10.1016/j.ijcard.2016.09.016. Epub 2016 Sep 13.

PMID:
27665403
2.

MicroRNA Expression in Coronary Artery Disease.

O'Sullivan JF, Neylon A, McGorrian C, Blake GJ.

Microrna. 2014;2(3):205-11. Review.

PMID:
25069444
3.

The Brady Bunch? New evidence for nominative determinism in patients' health: retrospective, population based cohort study.

Keaney JJ, Groarke JD, Galvin Z, McGorrian C, McCann HA, Sugrue D, Keelan E, Galvin J, Blake G, Mahon NG, O'Neill J.

BMJ. 2013 Dec 12;347:f6627. doi: 10.1136/bmj.f6627.

4.

A global perspective on psychosocial risk factors for cardiovascular disease.

Neylon A, Canniffe C, Anand S, Kreatsoulas C, Blake GJ, Sugrue D, McGorrian C.

Prog Cardiovasc Dis. 2013 May-Jun;55(6):574-81. doi: 10.1016/j.pcad.2013.03.009. Review.

PMID:
23621967
5.

The risks in risk prediction.

McGorrian C, Blake GJ.

BMJ. 2012 Jun 21;344:e4215. doi: 10.1136/bmj.e4215. No abstract available.

PMID:
22723607
6.

Carotid sinus massage.

Cronin EM, Blake GJ.

J Cardiovasc Electrophysiol. 2011 May;22(5):600. doi: 10.1111/j.1540-8167.2010.01952.x. Epub 2010 Nov 18. No abstract available.

PMID:
21561504
7.

The Dublin cardiac arrest registry: temporal improvement in survival from out-of-hospital cardiac arrest reflects improved pre-hospital emergency care.

Margey R, Browne L, Murphy E, O'Reilly M, Mahon N, Blake G, McCann H, Sugrue D, Galvin J.

Europace. 2011 Aug;13(8):1157-65. doi: 10.1093/europace/eur092. Epub 2011 Apr 6.

PMID:
21474456
8.

Ruptured noncoronary sinus of valsalva aneurysm: an unusual cause of chronic right-sided heart failure.

Cronin EM, Walsh KP, Blake GJ.

Circ Heart Fail. 2011 Jan;4(1):e3-4. doi: 10.1161/CIRCHEARTFAILURE.110.959221. No abstract available.

9.

Contemporary management of and outcomes from cardiac device related infections.

Margey R, McCann H, Blake G, Keelan E, Galvin J, Lynch M, Mahon N, Sugrue D, O'Neill J.

Europace. 2010 Jan;12(1):64-70. doi: 10.1093/europace/eup362.

PMID:
19910314
10.

Antiplatelet agents in the perioperative period.

O'Riordan JM, Margey RJ, Blake G, O'Connell PR.

Arch Surg. 2009 Jan;144(1):69-76; discussion 76. doi: 10.1001/archsurg.144.1.69. Review.

PMID:
19153328
11.

Long-term follow-up of the West of Scotland Coronary Prevention Study.

McEvoy JW, Margey R, Blake GJ.

N Engl J Med. 2008 Jan 10;358(2):193; author reply 194-5. doi: 10.1056/NEJMc076463. No abstract available.

12.

Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment.

Sabatine MS, Blake GJ, Drazner MH, Morrow DA, Scirica BM, Murphy SA, McCabe CH, Weintraub WS, Gibson CM, Cannon CP.

Circulation. 2005 Mar 15;111(10):1217-24.

13.

Postinfarction ventricular septal defect with pseudoaneurysm repair after failed percutaneous closure.

Paul S, Mihaljevic T, Leacche M, Landzberg M, Ho CY, Blake GJ, Byrne JG.

Ann Thorac Surg. 2005 Feb;79(2):701-3.

PMID:
15680870
14.

Hemoglobin A1c level and future cardiovascular events among women.

Blake GJ, Pradhan AD, Manson JE, Williams GR, Buring J, Ridker PM, Glynn RJ.

Arch Intern Med. 2004 Apr 12;164(7):757-61.

PMID:
15078645
15.

C-reactive protein and the risk of developing hypertension.

Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM.

JAMA. 2003 Dec 10;290(22):2945-51.

PMID:
14665655
16.

Blood pressure, C-reactive protein, and risk of future cardiovascular events.

Blake GJ, Rifai N, Buring JE, Ridker PM.

Circulation. 2003 Dec 16;108(24):2993-9. Epub 2003 Nov 24. Erratum in: Circulation. 2007 May 22;115(20):e537.

17.
18.

C-reactive protein: a surrogate risk marker or mediator of atherothrombosis?

Blake GJ, Ridker PM.

Am J Physiol Regul Integr Comp Physiol. 2003 Nov;285(5):R1250-2. Review. No abstract available.

19.

Inflammatory biomarkers of the patient with myocardial insufficiency.

Blake GJ.

Curr Opin Crit Care. 2003 Oct;9(5):369-74. Review.

PMID:
14508149
21.

C-reactive protein and other inflammatory risk markers in acute coronary syndromes.

Blake GJ, Ridker PM.

J Am Coll Cardiol. 2003 Feb 19;41(4 Suppl S):37S-42S. Review.

22.

Soluble CD40 ligand levels indicate lipid accumulation in carotid atheroma: an in vivo study with high-resolution MRI.

Blake GJ, Ostfeld RJ, Yucel EK, Varo N, Schönbeck U, Blake MA, Gerhard M, Ridker PM, Libby P, Lee RT.

Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):e11-4. Erratum in: Arterioscler Thromb Vasc Biol. 2003 Feb 1 ;23(2):363..

23.

C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events.

Blake GJ, Ridker PM.

Arterioscler Thromb Vasc Biol. 2002 Oct 1;22(10):1512-3. Review. No abstract available.

25.
27.

Are statins anti-inflammatory?

Blake GJ, Ridker PM.

Curr Control Trials Cardiovasc Med. 2000;1(3):161-165.

Supplemental Content

Loading ...
Support Center